DR.ESLEE TRIPLE ACTION BB- adenosine cream

Dr.eslee Triple Action BB by

Drug Labeling and Warnings

Dr.eslee Triple Action BB by is a Otc medication manufactured, distributed, or labeled by Ajou Medics Co., Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

active ingredient: adenosine

INACTIVE INGREDIENT

inactive ingredient:  Water, Butylene Glycol, Dipropylene Glycol, Cetyl Ethylhexanoate, Ethylhexyl Methoxycinnamate, Caprylic/Capric Triglyceride, Triethylhexanoin, Talc, Dimethicone, Phenyl Trimethicone, Isoamyl p-Methoxycinnamate, Arbutin, Cetyl PEG/PPG-10/1 Dimethicone, Zinc Oxide, Magnesium Sulfate, Polyglyceryl-4 Isostearate, Iron Oxides (CI 77492), Dipentaerythrityl Hexahydroxystearate / Hexastearate / Hexarosinate, Macadamia Integrifolia Seed Oil, Simmondsia Chinensis (Jojoba) Seed Oil, Beeswax, Microcrystalline Wax, Disteardimonium Hectorite, Sorbitan Sesquioleate, Panthenol, Iron Oxides (CI 77499), Iron Oxides (CI 77491), Aluminum Hydroxide, Tocopheryl Acetate, Triethoxycaprylylsilane, Allantoin, Bisabolol, Farnesyl Acetate, Farnesol , Panthenyl Triacetate, PEG-8, Piper Methysticum Leaf/Root/Stem Extract, PEG-, /SMDI Copolymer, Aloe Barbadensis Leaf Juice, Portulaca Oleracea Extract,
Chamaecyparis Obtusa Water, Hydrolyzed Collagen, Sodium Hyaluronate, Acetyl Hexapeptide-8, , Phenoxyethanol, Methylparaben, Propylparaben , Butylparaben, Fragrance

PURPOSE

Helps to protect from UV-Rays, skin whitening and wrinkle removing.

KEEP OUT OF REACH OF CHILDREN

keep out of reach of the children

INDICATIONS & USAGE

Apply Proper Amount of the cream on skin.

WARNINGS

■ For external use only.
■ Avoid contact with eyes.
■ Do not swallow. If swallowed, get medical help.
■ Keep out of reach of children.
■ Stop use and ask doctor if rash and irritation develops.

DOSAGE & ADMINISTRATION

wash the skin to be applied

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

DR.ESLEE TRIPLE ACTION BB 
adenosine cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 76340-6001
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567)	ADENOSINE	0.2 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
DIPROPYLENE GLYCOL (UNII: E107L85C40)
CETYL ETHYLHEXANOATE (UNII: 134647WMX4)
TRICAPRIN (UNII: O1PB8EU98M)
TRIETHYLHEXANOIN (UNII: 7K3W1BIU6K)
TALC (UNII: 7SEV7J4R1U)
DIMETHICONE (UNII: 92RU3N3Y1O)
ARBUTIN (UNII: C5INA23HXF)
ZINC OXIDE (UNII: SOI2LOH54Z)
MAGNESIUM SULFATE, UNSPECIFIED (UNII: DE08037SAB)
FERRIC OXIDE RED (UNII: 1K09F3G675)
MACADAMIA OIL (UNII: 515610SU8C)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 76340-6001-1	60 g in 1 TUBE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		09/13/2011

Labeler - Ajou Medics Co., Ltd (688796473)

Registrant - Ajou Medics Co., Ltd (688796473)

Establishment
Name	Address	ID/FEI	Business Operations
Ajou Medics Co., Ltd		688796473	manufacture